p53 Codon 72 polymorphism and the risk of esophageal squamous cell carcinoma
Authors:
- 4 October 2007
- journal article
- research article
- Published by Wiley in Molecular Carcinogenesis
- Vol. 47 (2) , 100-104
Abstract
The polymorphisms of the tumor suppressor gene p53 have been extensively investigated in numerous malignant tumors, particularly carcinomas associated with human papillomavirus (HPV) infection. However, the results remain controversial. To address a potential correlation between the p53 genotypes and the risk of esophageal squamous cell carcinoma (ESCC), we investigated the p53 codon 72 polymorphism in 435 patients with ESCC and 550 cancer‐free subjects from the same geographical region. p53 Arg/Arg genotype was significantly increased in ESCC cases compared with control subjects (85.7 vs. 49.6%, P < 0.001), resulting in an elevated ESCC risk (OR = 6.48, 95% CI = 4.65–9.03). In addition, among p53 Arg/Arg carriers, HPV infection, smoking, and drinking might further increase the risk of ESCC development.Keywords
This publication has 21 references indexed in Scilit:
- Polymorphisms in the p53 pathwayOncogene, 2006
- The Role ofP53andMDM2Polymorphisms in the Risk of Esophageal Squamous Cell CarcinomaCancer Research, 2005
- LMP7/TAP2 gene polymorphisms and HPV infection in esophageal carcinoma patients from a high incidence area in ChinaCarcinogenesis, 2005
- Histological precursors of oesophageal squamous cell carcinoma: results from a 13 year prospective follow up study in a high risk populationGut, 2005
- p53 Codon 72 Polymorphic Variants, Loss of Allele-Specific Transcription, and Human Papilloma Virus 16 and/or 18 E6 Messenger RNA Expression in Squamous Cell Carcinomas of the Head and NeckCancer Epidemiology, Biomarkers & Prevention, 2004
- p53 polymorphism in human papillomavirus-associated Kazakh’s esophageal cancer in Xinjiang, ChinaWorld Journal of Gastroenterology, 2004
- Esophageal CancerNew England Journal of Medicine, 2003
- Codon 72 polymorphism of p53 and its association with cervical cancerThe Lancet, 1999
- p53 Mutations in Human CancersScience, 1991
- Primary structure polymorphism at amino acid residue 72 of human p53.Molecular and Cellular Biology, 1987